Bottom line
VPMCX vs OZEM: the short answer
VPMCX (Vanguard PRIMECAP Fund) and OZEM (Roundhill GLP-1 & Weight Loss ETF) are quite different portfolios: only about 16% of their top holdings (by weight) are shared.
But VPMCX is far broader, holding 173 positions to 26 for OZEM, so beyond the top names it adds exposure OZEM doesn't have.
VPMCX is cheaper at 0.35% vs 0.59% — a difference of $24 a year per $10,000 invested.
Over one year, OZEM returned +41.4% vs +29.9% for VPMCX.
Updated Nov 19, 2026
VPMCX vs OZEM side by side
| VPMCX | OZEM | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Vanguard | Roundhill |
| Category | Large Blend | Large Blend |
| Expense ratio | 0.35% | 0.59% |
| Annual cost per $10k | $35 | $59 |
| 10-yr cost on $10k (prospectus) | $443 | $738 |
| Max front load | 0% | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +29.9% | +41.4% |
| 5-yr return (annualized) | +14.3% | — |
| 10-yr return (annualized) | +15.2% | — |
| Best quarter | +17.3% | +26.7% |
| Worst quarter | −20.2% | −3.2% |
| Net assets (fund) | $96.1B | $54.1M |
| Number of holdings | 173 | 26 |
| Portfolio turnover | 11% | 66% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | VPMCX | OZEM | Difference |
|---|---|---|---|
| 2025 | +29.9% | +41.4% | −11.5% |
Source: Fund prospectus bar charts
Holdings overlap
3 of VPMCX's top 25 holdings also appear in OZEM's top 25.
| Holding | VPMCX | OZEM |
|---|---|---|
| Eli Lilly & Co | 6.76% | 12.69% |
| AstraZeneca PLC | 2.35% | 3.83% |
| Amgen Inc | 1.64% | 3.85% |
Source: SEC Form N-PORT
VPMCX top 10
- Micron Technology Inc — 13.50%
- Intel Corp — 6.80%
- Eli Lilly & Co — 6.76%
- KLA Corp — 3.85%
- Alphabet Inc — 3.52%
- AstraZeneca PLC — 2.35%
- NVIDIA Corp — 2.33%
- Amazon.com Inc — 2.05%
- Tesla Inc — 1.89%
- Biogen Inc — 1.88%
OZEM top 10
- Novo Nordisk A/S — 12.96%
- Eli Lilly & Co — 12.69%
- Mount Vernon Liquid Assets Portfolio, LLC — 9.93%
- Pfizer Inc — 6.38%
- Kailera Therapeutics Inc — 6.21%
- Viking Therapeutics Inc — 5.86%
- CSPC Pharmaceutical Group Ltd — 5.32%
- Chugai Pharmaceutical Co Ltd — 4.51%
- Ascletis Pharma Inc — 4.20%
- Zealand Pharma A/S — 3.92%
FAQ
What is the difference between VPMCX and OZEM?
Which is cheaper, VPMCX or OZEM?
Should I own both VPMCX and OZEM?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.